Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use

1. A compound of the formula (I):

in which:

A is, with the C—N bond of the benzimidazole unit with which it is fused, a 4- to 7-membered monocyclic heterocycle or monocyclic heteroaryl, containing from one to three heteroatoms selected from O, S and N, including the nitrogen atom of the benzimidazole unit;

P is an 8-, 9-, 10- or 11-membered bicyclic heterocycle or bicyclic heteroaryl, containing from 1 to 6 heteroatoms selected from N, O and S; P being linked to the —C(Y)— group by a carbon atom;

with the proviso that, when A is a 7-membered saturated heterocycle, P is other than the 2,3-dihydro-1,4-benzodioxane group, the 1-benzopyran-2-one group and the isoindole group;

R1 is substituted on P one to four times and each R1 may be identical or different, R1 selected from a hydrogen atom, a halogen atom, and an oxo, thio, C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, aryloxy-C 1 -C 6 -alkyl, heteroaryloxy-C 1 -C 6 -alkyl, aryl-C 1 -C 3 -alkylenoxy-C 1 -C 6 -alkyl, heteroaryl-C 1 -C 3 -alkylenoxy-C 1 -C 6 -alkyl, arylthio-C 1 -C 6 -alkyl, heteroarylthio-C 1 -C 6 -alkyl, aryl-C 1 -C 3 -alkylenethio-C 1 -C 6 -alkyl, heteroaryl-C 1 -C 3 -alkylenethio-C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 3 -C 7 -cycloalkyloxy, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylenoxy, C 1 -C 6 -fluoroalkoxy, cyano, C(O)NR 4 R 5 , nitro, NR 4 R 5 , C 1 -C 6 -thioalkyl, C 3 -C 7 -cycloalkylthio, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylenethio, —S(O)—C 1 -C 6 -alkyl, —S(O)—C 3 -C 7 -cycloalkyl, —S(O)—C 1 -C 3 -alkylene-C 3 -C 7 -cycloalkyl, C 1 -C 6 -alkyl-S(O) 2 —, C 1 -C 6 -fluoroalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-S(O) 2 —, SO 2 NR 4 R 5 , SF 5 , NR 6 C(O)R 7 , NR 6 SO 2 R 8 , R 4 R 5 NC(O)—C 1 -C 3 -alkylene, aryl, heteroaryl, aryl-C 1 -C 5 -alkylene, heteroaryl-C 1 -C 5 -alkylene, aryloxy, arylthio, heteroaryloxy or heteroarylthio group;

said heteroaryl or aryl groups of R1 being optionally substituted with one or more substituents R 9 , which may be identical to or different from one another;

with the proviso that, when R1 is attached to a nitrogen atom of P, then R1 is not a halogen atom, an oxo, thio, cyano, nitro, SF 5 , NR 4 R 5 , C 1 -C 6 -thioalkyl, thioaryl, thioheteroaryl, C 1 -C 6 -alkoxy, aryloxy, heteroaryloxy, —NR 6 COR 7 or NR 6 SO 2 R 8 group;

Y is an oxygen or sulphur atom;

R2 is a hydrogen atom, a halogen atom, or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl or C 1 -C 6 -alkoxy group;

R3 is substituted on a carbon atom of A, each R3 may be substituted 1 to 3 times on a carbon atom of A, each R3 substituted on a carbon atom of A may be identical or different, said R3 substituted on a carbon atom of A selected from hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, hydroxyl, C 1 -C 6 -alkoxy, C 3 -C 7 -cycloalkyloxy and C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylenoxy group;

or

R3 is substituted on a nitrogen atom of A, each R3 may be substituted once or twice on a nitrogen atom of A and may be identical or different, said R3 substituted on a nitrogen atom of A selected from hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, aryl-C(O)—, C 1 -C 6 -alkyl-C(O)—, C 3 -C 7 -cycloalkyl-C(O)—, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-C(O)—, C 1 -C 6 -fluoroalkyl-C(O)—, aryl-S(O) 2 —, C 1 -C 6 -alkyl-S(O) 2 —, C 1 -C 6 -fluoro-alkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-S(O) 2 —, C 1 -C 6 -alkyl-O—C(O)—, aryl-C 1 -C 3 -alkyl-O—C(O)—, C 3 -C 7 -cycloalkyl-O—C(O)—, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-O—C(O)—, C 1 -C 6 -fluoroalkyl-O—C(O)—, aryl-O—C(O)— or heteroaryl-O—C(O)— group;

R 4 and R 5 are, independently of one another, a hydrogen atom or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, aryl-C 1 -C 5 -alkylene or aryl group;

or R 4 and R 5 form, together with the nitrogen atom which carries them, an azetidine, pyrrolidine, piperidine, azepine, morpholine, thiomorpholine, piperazine or homopiperazine group, the NR 4 R 5 group being optionally substituted with a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, aryl-C 1 -C 6 -alkylene, aryl, heteroaryl, aryl-S(O) 2 —, C 1 -C 6 -alkyl-S(O) 2 —, C 1 -C 6 -fluoroalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-S(O) 2 —, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-S(O) 2 —, aryl-C(O)—, C 1 -C 6 -alkyl-C(O)—, C 3 -C 7 -cycloalkyl-C(O)—, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene-C(O)—, C 1 -C 6 -fluoroalkyl-C(O)—, hydroxyl, C 1 -C 6 -alkyloxy, C 1 -C 6 -fluoroalkyl, aryloxy-C 1 -C 6 -alkylene, aryloxy, heteroaryloxy-C 1 -C 6 -alkylene or heteroaryloxy group;

R 6 and R 7 are, independently of one another, a hydrogen atom, or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, aryl-C 1 -C 6 -alkylene or aryl group;

or R 6 and R 7 together form a 4- to 7-membered lactam comprising the nitrogen atom and the C(O) group which carry them;

R 8 is a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, aryl-C 1 -C 6 -alkylene or aryl group;

or R 6 and R 8 together form a 4- to 7-membered sultam comprising the nitrogen atom and the S(O) 2 group which carry them;

R 9 is a halogen atom, or a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, nitro, cyano, NR 4 R 5 , R 4 R 5 N—C 1 -C 3 -alkylene, aryl, heteroaryl, aryloxy, arylthio, heteroaryloxy or heteroarylthio group, said heteroaryl or aryl groups being optionally substituted with one or more substituents selected from a halogen atom, and a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, nitro, cyano, NR 4 R 5 or R 4 R 5 N—C 1 -C 3 -alkylene group;

the sulphur atom(s) of the heterocycle A may be in oxidized form (S(O) or S(O) 2 );

the nitrogen atom(s) may be in oxidized form (N-oxide);

or an addition salt thereof; and with the proviso that 2-(2-chlorophenyl)-1,3-dioxo-N-(7,8,9,10-tetrahydro-6H-azepino[1,2-a]benzimidazol-3-yl)isoindoline-5-carboxamide is excluded.

2. The compound according to claim 1 , which is of formula (II):

in which:

X is a carbon atom or a nitrogen atom; said X being identical to or different from one another and the number of X═N not being greater than 2;

R2, R3, Y and A being as defined in formula (I) according to claim 1 ;

and each R1 maybe the same or different and is defined as in Formula I according to claim 1 ; or an addition salt thereof.

3. The compound according to claim 2 , which is of formula (III):

in which:

R 1a is bonded to the ring containing X atoms one or more times, each R 1a may be identical or different, each R 1a is selected from hydrogen, a halogen a C 1 -C 6 -alkyl, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -thioalkyl, C 1 -C 6 -alkyl-S(O) 2 —, NR 4 R 5 and nitro group;

R 1b is a hydrogen atom, or a C 1 -C 6 -alkyl, heteroaryloxy-C 1 -C 6 -alkyl, aryl-C 1 -C 3 -alkylenoxy-C 1 -C 6 -alkyl, R 4 R 5 NC(O)—C 1 -C 3 -alkylene, aryl, heteroaryl, aryl-C 1 -C 6 -alkylene or heteroaryl-C 1 -C 6 -alkylene group;

said heteroaryl or aryl groups of R 1b being optionally substituted with one or more substituents R 9 , which may be identical to or different from one another;

R 9 is a halogen atom or a C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkyl, aryl, heteroaryl, NR 4 R 5 or arylthio group, said heteroaryl or aryl groups being optionally substituted with one or more substituents selected from a halogen atom, and a C 1 -C 6 -alkyl, C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylene, C 1 -C 6 -fluoroalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkoxy, nitro, cyano or R 4 R 5 N—C 1 -C 3 -alkylene group;

R2, R3, R 4 , R 5 , A, X and Y are as defined in formula (II) according to claim 2 ;

or an addition salt thereof.

4. The compound according to claim 1 , which is of formula (IV):

in which W is a tricyclic heterocycle or a tricyclic heteroaryl selected from:

and wherein:

R1, R2, R3, P and Y being as defined in formula (I) according to claim 1 ;

or an addition salt thereof.

5. The compound according to claim 1 , which is of formula (V):

in which:

R1, R2, R3, A and P are as defined in formula (I) according to claim 1 ;

or an addition salt thereof.

6. The compound according to claim 1 , which is of formula (V):

in which:

R2 is a hydrogen atom, or a C 1 -C 6 -alkyl or C 1 -C 6 -alkoxy group;

R3 is substituted on a carbon atom of A one to three times, each R3 substituted on a carbon atom of A may be identical or different, and is selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy and hydroxyl group;

or

R3 is substituted on a nitrogen atom of A, one to two times, each R3 substituted on a nitrogen atom of A may be identical or different, and is selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkyl-O—C(O)— and aryl-C 1 -C 3 -alkyl-O—C(O)— group; and wherein

R1, A and P are as defined in formula (I) according to claim 1 ;

or an addition salt thereof.

7. The compound according to claim 1 , which is of formula (V):

in which:

A is, with the C—N bond of the benzimidazole unit with which it is fused, a 5- to 7-membered monocyclic heterocycle or monocyclic heteroaryl containing from one to three heteroatoms selected from O, S and N, including the nitrogen atom of the benzimidazole unit; and wherein

R 1 , R 2 , R 3 , and P are as defined in formula (I) according to claim 1 ;

or an addition salt thereof.

8. The compound according to claim 1 , which is of formula (Va):

in which

A is, with the C—N bond of the benzimidazole unit with which it is fused, a 5- to 7-membered monocyclic heterocycle or monocyclic heteroaryl containing one or two heteroatoms selected from O, S and N, including the nitrogen atom of the benzimidazole unit;

X is a carbon atom or a nitrogen atom; said X being identical to or different from one another and the number of X═N not being greater than 1;

R 1a is one or more atoms or groups, which may be identical or different, selected from a hydrogen atom, a halogen atom or a C 1 -C 6 -alkyl group, a C 1 -C 6 -fluoroalkyl group, a C 1 -C 6 -alkoxy group, a C 1 -C 6 -thioalkyl group, a C 1 -C 6 -alkyl-S(O) 2 — group, an NR 4 R 5 group or a nitro group;

R 1b is a hydrogen atom, or a C 1 -C 6 -alkyl, heteroaryloxy-C 1 -C 6 -alkyl, aryl-C 1 -C 3 -alkylenoxy-C 1 -C 6 -alkyl, R 4 R 5 NC(O)—C 1 -C 3 -alkylene, aryl, heteroaryl, aryl-C 1 -C 6 -alkylene or heteroaryl-C 1 -C 6 -alkylene group;

said heteroaryl or aryl groups of R 1b being optionally substituted with one or more substituents R 9 , which may be identical to or different from one another;

R2 is a hydrogen atom;

R3 is substituted on a carbon atom of X, and selected from hydrogen, C 1 -C 6 -alkyl, 6 C 1 -C 6 -alkoxy, and hydroxyl;

or

R3 is substituted on a nitrogen atom of X, and is selected from hydrogen, a C 1 -C 6 -alkyl group and a C 1 -C 6 -alkyl-O—C(O)— group;

R 4 and R 5 are, independently of one another, a C 1 -C 6 -alkyl group;

or R 4 and R 5 form, together with the nitrogen atom which carries them, a pyrrolidine or morpholine group; and

R 9 is a halogen atom or a C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -fluoroalkyl, aryl, heteroaryl, NR 4 R 5 , or arylthio group, said aryl groups being optionally substituted with one or more C 1 -C 6 -alkyl groups;

or an addition salt thereof.

9. A process for preparing a compound of formula (I) according to claim 1 comprising:

reacting a compound of formula (VI):

in which P, R1 and Y are as defined in formula (I) according to claim 1 and B is a C 1 -C 6 -alkoxy, C 3 -C 7 -cycloalkyloxy, C 3 -C 7 -cycloalkyl-C 1 -C 3 -alkylenoxy or aryl-C 1 -C 3 -alkylenoxy group, with the resulting amide formed from the reaction of trimethyl-aluminum on the amine of formula VII:

in which A, R2 and R3 are as defined in formula (I) according to claim 1 .

10. A process for preparing a compound of formula (I) according to claim 1 comprising:

converting a compound of formula (VI):

in which P, R1 and Y are as defined in formula (I) according to claim 1 and B is a hydroxyl group, to an acid chloride by the action of thionyl chloride at the reflux of a solvent, and

reacting the compound of formula (VI) obtained therefrom, in which P, R1 and Y are as defined in formula (I) according to claim 1 and B is a chlorine atom, in the presence of a base, with the compound of formula (VII):

in which A, R2 and R3 are as defined in formula (I) according to claim 1 ;

or

subjecting to a coupling reaction a compound of formula (VI), in which P, R1 and Y are as defined in formula (I) according to claim 1 and B is a hydroxyl group, and a compound of formula (VII) in which A, R2 and R3 are as defined in formula (I) according to claim 1 , in the presence of a coupling agent and a base in a solvent.

11. A compound of formula (VIIa), (VIIb), (VIIc), (VIId), (VIIe), (VIIf), (VIIg), (VIIh), (VIIi), (VIIj), (VIIk), (VIIl), (VIIm) or (VIIn):

12. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 1 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

13. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 2 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

14. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 3 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

15. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 4 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

16. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 5 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

17. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 6 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

18. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 7 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.

19. A pharmaceutical composition comprising at least one compound of formula (I) according to claim 8 or a pharmaceutically acceptable salt thereof in combination with at least one pharmaceutically acceptable excipient.